对于肝细胞癌的新辅助全身疗法
R Connor Chick1, Samantha M Ruff1, Timothy M Pawlik1
1Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, United States.
Frontiers in immunology
|March 18, 2024
概括
新辅助性全身疗法,结合免疫检查点抑制剂和向药物,显示出对肝癌 (肝细胞癌) 的承诺. 需要进一步的大规模试验来确认其在手术或移植之前的长期有效性.
科学领域:
- 肝胆道手术 肝胆道手术
- 医学瘤学 医学瘤学
- 肝细胞癌研究 肝细胞癌研究
背景情况:
- 手术切除和肝移植是肝细胞癌 (HCC) 的主要治疗方法.
- 从历史上看,HCC的全身疗法有效性有限.
- 最近的进展包括免疫检查点抑制剂和向疗法,提供了新的希望.
研究的目的:
- 调查新辅助全身疗法的作用和疗效,在切除或局部晚期HCC.患者.
- 总结了早期阶段试验的发现,这些试验探索了新的全身疗法组合.
- 突出了对长期瘤结果的进一步研究的需要.
主要方法:
- 已完成和正在进行的临床试验的审查,涉及HCC的新辅助全身治疗.
- 对治疗组合的分析,包括免疫检查点抑制剂,氨酸激酶抑制剂,跨动脉疗法和辐射.
- 专注于早期试验结果和正在进行的调查.
主要成果:
- 在HCC中新辅助系统治疗的早期试验显示出令人鼓舞的结果.
- 目前正在积极研究系统疗法,跨动脉疗法和辐射的组合.
- 通过免疫检查点抑制剂和向疗法观察到有希望的结果.
结论:
- 新辅助性全身疗法是HCC管理的快速发展领域.
- 虽然早期的结果是有希望的,但更大的试验对于建立长期益处至关重要.
- 新辅助系统治疗与治愈意向治疗结合的最佳作用需要进一步定义.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
10.3K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
